Anticoagulation Desktop Reference

Anticoagulation Toolkit (Version ). A Consortium-Developed Quick Reference for Anticoagulation This toolkit was produced by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a consortium of Anticoagulation clinics and experts from across the state of Michigan. Funding for MAQI2 is provided by Blue Cross Blue Shield of Michigan and Blue Care Network through the Collaborative Quality Improvement (CQI) program. The goal of this toolkit is to provide practitioners with an up-to-date, reliable, and easy to use source of information for Anticoagulation . The content is based on the latest available evidence-based guidelines and research whenever possible. If you are aware of new guidelines or research, or if you have suggestions that can help improve this toolkit, please email us to let us know. What's new in version Added a new section for Anticoagulation in special populations, including information on AF and VTE. in pregnancy and patients requiring multiple anti-thrombotic therapy Added a new section on drug - drug and drug -natural supplement interactions with DOACs Added information on warfarin reversal Numerous other updates based on the latest CHEST, AHA/ACC, ASH, and AC Forum guidelines Disclaimer: This toolkit is for informational purposes only and does not, itself, constitute medical advice.

Elderly 1 D urrent drugs (medication) or alcohol use (1pt each) 1 or 2 TOTAL POINTS Total Points Annual Major bleed risk (%) Intracranial bleeds per 100-pt-yrs3 Major bleed risk category 0 1.13 Low 1 1.02 Low 2 1.88 0.6 Intermediate 3 3.74 0.7 High 4 8.7 1.0 High 5 12.5 1.2 High

Loading..

Tags:

  Drug, Elderly, Anticoagulation

Information

Related search queries